HUM241227C160000
- 0.00
- 0.000.00%
Humana Newsroom
Buckle up! Goldman Sachs: Market optimism is nearing its peak, Bullish on two defensive Sectors.
①Goldman Sachs advises investors to take more "defensive measures" as Wall Street's optimism about the USA economy and stock market approaches historical highs. ②Goldman Sachs' model is bullish on the performance of defensive stocks such as utilities and Medical Care.
Express News | RPT-Buzz-US Stocks Weekly: Snow Squall
Musk causes a commotion at Capitol Hill, is a "Trump 2.0" prototype emerging?
Analysis suggests that Musk's recent act of detonating a political nuclear bomb may be a rehearsal for the Trump 2.0 era of Musk's action model, intended to exert pressure on Congress. However, some also say that the consensus at Mar-a-Lago is that Musk has proven to be an effective Weapon to pressure Congress and a scapegoat for any backlash.
Equities Rise Intraday as Traders Assess Macro Data
Baird Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $270
Unusual Options Activity: HIMS, FN and Others Attract Market Bets, HIMS V/OI Ratio Reaches 115.4
EST Dec 20th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Government Shutdown Threat: Stocks Wobble, Holiday Travel And Paychecks Could Face Delays: What You Need To Know
Express News | Humana Names Japan Mehta as Chief Information Officer
This week's US stock market hot stocks | The US version of HAIDILAO exceeds expectations! Darden Restaurants' stock price skyrocketed nearly 15%; Boeing, a component of the Dow, rose 4.36% against the trend this week, receiving a large order for 737 MAX a
This week, the Dow Jones Industrial Average has fallen by 3.39%, closing at 42,342.24 points; during the same period, the S&P 500 Index has decreased by 3.04%, closing at 5,867.08 points; the Nasdaq has dropped by 2.78%, closing at 19,372.77 points.
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Baird Adjusts Humana Price Target to $270 From $374, Maintains Neutral Rating
Trump's tariff plan is unpopular! More than half of the USA population opposes imposing taxes on commodities from Mexico.
Standard & Poor's stated that the tariffs in the USA will raise inflation rates and reduce economic output, while some individuals and businesses are stockpiling goods in anticipation of tariff concerns, leading to a significant increase in throughput at the Port of Los Angeles and Long Beach in November.
Stocks Down 10% or More: Humana, Marvell, and Amentum
Morgan Stanley raises the Target Price for Humana to $301.
Gelonghui, December 18 | Morgan Stanley: Raised the Target Price for Humana from $288 to $301, maintaining a "Neutral" rating. (Gelonghui)
Clover Health Draws New Buy at Craig-Hallum Despite Sharp YTD Gains
Top Stock Movers Now: Amentum Holdings, Humana, Nvidia, and More
Humana Stock Falls Amid Concerns Over Veterans' Plan Earnings Exposure
Humana Is Maintained at Equal-Weight by Morgan Stanley
Humana Analyst Ratings